Spectral data analyses and structure elucidation of metoprolol tartrate

Drug Testing and Analysis

Volumn 3, Issue 6, 2011, Pages 387-392

  Qiao, Jun Qin ^a   Wang, Ya Qin ^b   Liu, Chen Chen ^a   Zhu, Wei ^a   Lian, Hong Zhen ^a   Ge, Xin ^a  

^a NANJING UNIVERSITY   (China)

^b ANHUI JIANZHU UNIVERSITY   (China)

Author keywords

Infrared spectrum (IR); Mass spectra (MS); Metoprolol tartrate (MT); Nuclear magnetic resonance (NMR); Ultraviolet spectrum (UV)

Indexed keywords

ELECTRON TRANSITIONS; MASS SPECTROMETERS; MASS SPECTROMETRY; ULTRAVIOLET SPECTROSCOPY;

INFRARED SPECTRUM; MASS SPECTRA; MASS SPECTRUM; METOPROLOL TARTRATE; NUCLEAR MAGNETIC RESONANCE; ULTRA-VIOLET SPECTRUMS; ULTRAVIOLET SPECTRUM;

NUCLEAR MAGNETIC RESONANCE;

METOPROLOL TARTRATE;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; DATA ANALYSIS; DRUG STRUCTURE; INFRARED SPECTROMETRY; MASS SPECTROMETRY; POLARIZATION; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; ULTRAVIOLET SPECTROSCOPY;

EID: 79959536857     PISSN: 19427603     EISSN: 19427611     Source Type: Journal    
DOI: 10.1002/dta.257     Document Type: Article

References (20)

1. M. Remiszewska, Z. Jastrzebski, H. Czyzewska-Szafran, M. Wutkiewicz, Eur. J. Pharmacol. 1993, 250, 355.
2. R. C. Ahuja, N. Sinha, R. Ravi Kumar, R. K. Saran, Int. J. Cardiol. 1993, 41, 191.
3. MERIT-HF Study Group. Lancet 1999, 353, 2001.
4. B. A. Groenning, J. C. Nilsson, L. Sondergaard, T. Fritz-Hansen, H. B. W. Larsson, P. R. Hildebrandt, J. Am. Coll. Cardiol. 2000, 36, 2072.
5. The United States Pharmacopoeia Convention, USP30-NF25, United States Pharmacopeial: Rockville, MD, p. 2649.
6. V. M. Karapandzic, B. D. Vujisic-Tesic, P. M. Pesko, B. M. Nenadic, D. D. Babic, J. Clin. Anesth. 2008, 20, 284.
7. A. S. Go, J. R. Yang, J. H. Gurwitz, J. Hsu, K. Lane, R. Platt, Arch. Intern. Med. 2008, 168, 2415.
8. M. Aqil, A. Ali, Y. Sultana, N. Saha. Clin. Drug Invest. 2007, 27, 833.
9. M. Metra, L. D. Cas, J. G. F. Cleland, J. Card. Fail. 2006, 12, 177.
10. M. Jasińska, B. Karwowski, D. Orszulak-Michalak, U. Kurczewska, Acta Pol. Pharm. 2009, 66, 697.
11. K. V. Gowda, U. Mandal, P. S. Selvan, W. D. Sam Solomon, A. Ghosha, A. K. Sarkar, S. Agarwal, T. N. Raob, T. K. Pal, J. Chromatogr. B 2007, 858, 13.
12. H. Y. Liu, J. J. Ren, Y. H. Hao, P. G. He, Y. Z. Fang, J. Pharmaceut. Biomed. 2006, 42, 384.
13. M. Bharkatiya, R. K. Nema, A. Goyal, Ind. Pharm. 2009, 8, 79, 83.
14. B. Magdalena, B. Dan, C. Ioana, I. Mihaela, L. B. Daniela, Farmacia 2008, 66, 363.
15. G. P. Moloney, D. J. Craik, M. N. Iskander, T. L. Nero, J. Chem. Soc., Perkin Trans. 2 1998, 2, 199.
16. S. H. Jung, P. T. Linh, H. K. Lim, H. J. Kim, K. H. Kim, J. S. Kang, Arch. Pharm. Res. 2000, 23, 226.
17. M. S. Tehrani, M. T. Vardini, P. A. Azar, S. W. Husain, Chin. J. Chem. 2010, 28, 647.
18. C. Slegers, A. Maquille, W. Deridder, E. Sonveaux, J. L. H. Jiwan, B. Tilquin. Radiat. Phys. Chem. 2006, 75, 977.
19. M. Thevis, G. Opfermann, W. Schänzer, Biomed. Chromatogr. 2001, 15, 393.
20. M. Aqil, A. Ali, A. Ahad, Y. Sultana, A. K. Najmi, N. Saha, Acta Chromatogr. 2007, 19, 130.